Matthew Gavidia

Study findings suggest that the unique genomic variations of cerebrospinal fluid can be leveraged as a liquid biopsy to effectively and safely improve decision-making regarding treatment of patients with non–small cell lung cancer (NSCLC) with leptomeningeal metastasis.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Biologic-experienced patients with psoriasis exhibited significantly improved treatment adherence and lower discontinuation, nonpersistence, and switching rates over 18 months when prescribed ixekizumab vs secukinumab.

Adalimumab biosimilar AVT02 exhibited comparative efficacy, safety, tolerability, and immunogenicity to the reference drug Humira in patients with moderate-to-severe chronic plaque psoriasis.

A panel discussion at the CHEST Annual Meeting 2021 discussed disparities related to race, ethnicity, gender, and socioeconomic status that have been shown to impact access to high-quality lung cancer care.

Researchers at the CHEST Annual Meeting 2021 addressed the evolution of COVID-19 variants, how these emerging strains impact vaccines, and preventive recommendations for at-risk populations.

Panelists of a session at CHEST 2021 discuss the latest research regarding efficacy and safety of therapies in the management of asthma, including biologics, corticosteroids, and more.

Older individuals with a weekday bedtime later than midnight were associated with a greater risk of myocardial infarction. No elevated risks were observed according to weekend bedtimes.

More than 1 in 3 patients with Parkinson disease were found to experience minor hallucinations, which were linked with worse quality of life and poor sleep outcomes.

Pediatric populations, young adults, and parents all identified differing goals and preferences of treatment for psoriasis, with the most important treatment goals overall cited as lesion prevention and reduction.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Wearable accelerometer data from over 89,000 participants indicated that people with a mental illness diagnosis were more likely to have poor sleep quality than the general population.

A novel formulation of calcipotriene (CAL), betamethasone dipropionate (BDP) cream was found to be more effective, provide superior quality of life, and safe in patients with psoriasis, compared with standard CAL/BDP topical suspension/gel.

An evaluation of price transparency tools for ophthalmologic procedures found significant usability, availability, and variability issues, which may disproportionately impact vulnerable populations.

Patients with psoriatic arthritis (PsA) were found to be more likely to report musculoskeletal symptoms and dermatologic issues prior to initial PsA diagnosis.

Pediatric patients with extreme obstructive sleep apnea (OSA) may have a higher risk of needing respiratory support after undergoing corrective adenotonsillectomy, warranting the need for postoperative observation in these populations.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Patients with moderate to severe psoriasis were shown to achieve and maintain higher levels of complete skin clearance and quality of life when treated with brodalumab vs ustekinumab, regardless of the presence of lifestyle risk factors.

Male patients with young-onset type 2 diabetes were found to be at 72% greater risk of retinopathy compared with those who received a diagnosis at 50 years or older.

Patients with obstuctive sleep apnea were found to be significantly more likely to have brain white matter hyperintensities, lesions known to signal brain aging and potential risk of Alzheimer disease.

Women with poor sleep quality were found to be at more than 2 times greater risk of obesity, with this association occurring only in those who did not meet recommended dietary standards.

Secukinumab was associated with a high rate of short- and long-term drug survival in the treatment of patients with psoriasis, with factors such as obesity and prior biologic use linked to discontinuation of use.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Chronic disease caregivers are more likely to report both risky and health-promoting behaviors than noncaregivers, according to a new study.

Patients with a positive fecal immunochemistry test (FIT) were shown to be at significantly greater risk of developing psoriasis than those with FIT-negative tests.

Risk of diabetic retinopathy (DR) was found to be decreased in young patients with type 1 diabetes (T1D) who were treated with insulin pumps, with findings also indicating a 2.1-fold greater risk of DR in Black participants compared with White individuals.

Patients with periodontitis had a potential increased risk of developing psoriasis, particularly those who smoked.

A roundup of the latest news in sleep research reported across MJH Life Sciences™.

Greater body surface area was shown to correlate with an increased risk of psoriatic arthritis development in patients with psoriasis, with obesity and depression also identified as risk factors.

An inverse relationship between obstructive sleep apnea (OSA) and serum testosterone was found in men, in which those with severe cases of OSA exhibited significantly reduced levels of testosterone.